- Health
Brain Health round table event - EP BrainHealth
This round table event looks at how regional brain health ideas can reach a larger audience and seeks to encourage dialogue between innovation and implementation.
Read moreEvents
12:30 - 17:45
This was 1 year ago
Permanent Representation of Estonia to the EU, Brussels
Rue Guimard 11/13, 1040 Brussels, Belgium
Estonian Research Council Brussels Office and ScanBalt® are organising a seminar on the 13th of May 2025 to address the pressing need for innovation in the early diagnosis of Alzheimer’s and Parkinson’s disease.
Policymakers, industry experts and academia will collaborate to explore how to bridge policy, technology and healthcare for the future of neurogenerative disease diagnosis and care in Europe.
The seminar (12:30-17:45) will be followed by a networking reception (17:45-18:30).
You can find more information and the registration link here.
myOverview
Stay informed about Horizon Europe, Digital Europe & EDF, filtered on what matters to you.
Only for stakeholders located in Flanders
This round table event looks at how regional brain health ideas can reach a larger audience and seeks to encourage dialogue between innovation and implementation.
Read moreAs climate impacts intensify across Europe, this Forum will spotlight practical and replicable adaptation solutions that are making a difference on the ground. Participants will explore innovative tools being developed through Mission Projects to boost climate resilience, collaborate to co-design solutions tailored to their communities, and...
Read moreThe Disaster Resilience Days 2026 is a three-day European forum bringing together researchers, policymakers, civil protection authorities, first responders, critical infrastructure operators, security and defence actors, industry, and innovators to strengthen disaster resilience and crisis preparedness through research, innovation and...
Read moreThe European Institute of Innovation and Technology (EIT) Health Summit 2026 will take place in Madrid this year, in collaboration with the Madrid Regional Health Ministry. As EIT Health marks its tenth anniversary, this year’s Summit aims to provide an opportunity to reflect on what the community has achieved together over the past decade,...
Read moreTestimonial
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.